Marked prolongation of QRS duration after initiation of dronedarone therapy

Dronedarone is a relatively new antiarrhythmic drug and is held to be less proarrhythmic than comparable compounds, although its proarrhythmia potential in humans has not been sufficiently evaluated. We describe a so far unreported dronedarone effect, namely a significant alteration of both the morp...

Descripción completa

Detalles Bibliográficos
Autores principales: Genz, Conrad, Esperer, Hans D., Schmeisser, Alexander, Braun-Dullaeus, Ruediger C., Said, Samir M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wichtig 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774943/
https://www.ncbi.nlm.nih.gov/pubmed/27004096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774943/
https://www.ncbi.nlm.nih.gov/pubmed/27004096

Ejemplares similares